|
|
Volumn 22, Issue 5, 2008, Pages 1082-1083
|
|
Rituximab in CD20 positive multiple myeloma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
BORTEZOMIB;
CD20 ANTIGEN;
CD38 ANTIGEN;
CD56 ANTIGEN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN KAPPA CHAIN;
IMMUNOGLOBULIN LAMBDA CHAIN;
IMMUNOGLOBULIN M;
MELPHALAN;
PREDNISONE;
RITUXIMAB;
SYNDECAN 1;
VINCRISTINE;
ADULT;
APHERESIS;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BONE MARROW BIOPSY;
BONE PAIN;
CANCER REGRESSION;
CANCER RELAPSE;
CANCER STAGING;
CASE REPORT;
CELL INFILTRATION;
CYTOPLASM;
DRUG TREATMENT FAILURE;
HUMAN;
IMMUNOPHENOTYPING;
LETTER;
LYSIS SYNDROME;
MALE;
METABOLIC DISORDER;
MULTIPLE CYCLE TREATMENT;
MULTIPLE MYELOMA;
NEUTROPHIL;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PLASMA CELL;
PRIORITY JOURNAL;
SIDE EFFECT;
THROMBOCYTE COUNT;
|
|
EID: 43749085996
PISSN: 08876924
EISSN: 14765551
Source Type: Journal
DOI: 10.1038/sj.leu.2405010 Document Type: Letter |
|
Times cited : (7)
|
|
References (5)
|
